Stada secures third license for copycat biotech drug: CEO

BAD VILBEL Germany (Reuters) - Germany's Stada plans to bring a copy of Eli Lilly's Forteo osteoporosis treatment to market, its chief executive said, as the generic drugmaker moves further into the sale of cheaper alternatives for costly biotech drugs.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news